Press release
Mumbai Hosts Powerful Premiere of The Protagonist Show and Launch of Sheroes Amongst Us
Co-authored by Falguni Desai and Dr. Amit Nagpal, the book highlights real-life stories of women who transformed adversity into strength, inspiring audiences to recognize the hero within. These stories were brought to life through The Protagonist Show, an innovative family entertainer that merges literature with live-action narrative.
Jyoti Rai, Founder of Etherwire.ai and one of the featured Sheroes, shared, "We created a tribute that reimagines books as mainstream, heart-touching entertainment. It's a new way to honour authors and inspire families."
The evening resonated with students, professionals, and families. Emotional reflections poured in from speakers including Col. S.S. Chandhoke, Vaisshali Babu, and Ranjana Maitra, who praised the show's heartfelt message.
Filmmaker Shashie Verma, whose studio Sceneworks collaborated on the project, added, "This is just the beginning of telling a million untold stories."
Protagonists Dr. Shilpi Thapar, Rajani Tiwari, and Roma Balwani echoed the sentiment: "This wasn't just a celebration-it was a mirror, a movement, and a memory."
Mumbai
Insight Media is a forward-thinking media and communications company committed to creating impactful narratives across digital platforms. Established with a vision to bridge the gap between brands and their audiences, Insight Media specializes in content creation, public relations, and strategic communication services tailored to today's fast-paced digital landscape.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mumbai Hosts Powerful Premiere of The Protagonist Show and Launch of Sheroes Amongst Us here
News-ID: 4080068 • Views: β¦
More Releases for Protagonist
Beta-thalassemia (B-thal) Market Segmentation Application, Technology and Market β¦
The exclusive research report on 'Beta-thalassemia (B-thal) Market' now available with ππ¨π‘ππ«ππ§π πππ«π€ππ ππ§π¬π’π π‘ππ¬, offers a detailed analysis of the factors influencing the global business sphere. This report also provides precise information pertaining to market size, commercialization aspects and revenue estimation of this business. The report further elucidates the status of leading industry players thriving in the competitive spectrum of the Beta-thalassemia (B-thal) Market.
The research report incorporates a detailed evaluationβ¦
Investigation announced for Investors in Protagonist Therapeutics, Inc. (NASDAQ: β¦
An investigation was announced over potential breaches of fiduciary duties by certain directors at Protagonist Therapeutics, Inc.
Investors who purchased shares of Protagonist Therapeutics, Inc. (NASDAQ: PTGX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Protagonist Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.
Newark, CA based Protagonistβ¦
Investigation announced for Investors in shares of Protagonist Therapeutics, Inc β¦
An investigation was announced over potential securities laws violations by Protagonist Therapeutics, Inc. in connection with certain financial statements.
Investors who purchased shares of Protagonist Therapeutics, Inc. (NASDAQ: PTGX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Protagonist Therapeutics, Inc. regarding its business, its prospects and its operations wereβ¦
Global Beta-Thalassemia Market Report 2022, SWOT Analysis and Forecast 2030: Nov β¦
The global Beta-Thalassemia Market is estimated to be valued at US$ 411.8 million in 2022 and is expected to exhibit a CAGR of 7% over the forecast period (2022-2030).
Market Research, Inc. published a report titled "Beta-Thalassemia Market" research report which covers inclusive data on established trends, drivers, growth opportunities and restraints that can change the market dynamics of the global industry. This report provides an in-depth analysis of the marketβ¦
Global Hepcidin Market Insights 2021 β Daiichi Sankyo Co Ltd, Pieris Pharmaceu β¦
Market Strides' global Hepcidin market research reports cover the market overview-defining the characteristics, scale and growth, segmentation, regional segmentation, competitive landscape, market share, trends and strategies of Hepcidin industries. The market size part gives the market revenue, including historical data of the market and forecasts for the future. The driving factors and constraints of external factors affecting market growth are studied. Industry segmentation subdivides the key sub-sectors that make upβ¦
Hepcidin Market Outlook (2019-2025)| Daiichi Sankyo Co Ltd, Pieris Pharmaceutica β¦
The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Hepcidin market. It sheds light on how the global Hepcidin Market is expected to grow during the course of the forecast period. With SWOT analysis and Porterβs Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global Hepcidin market and different players operating therein.β¦
